English  |  正體中文  |  简体中文  |  Items with full text/Total items : 56577/90363 (63%)
Visitors : 11890098      Online Users : 69
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/50364


    Title: Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest
    Authors: Hsu, Shih-chung;Ou, Chien-chih;Li, Jhy-wei;莊子超;Chuang, Tzu-chao;Kuo, Han-pon;Liu, Jah-yao;Chen, Chin-shiang;Lin, Song-chow;Su, Ching-hua;Kao, Ming-ching
    Contributors: 淡江大學化學學系
    Keywords: Ganoderma tsugae;Lingzhi (Reishi);Colo205;Colorectal cancer;Cancer therapy
    Date: 2008-12-01
    Issue Date: 2010-08-09 15:53:02 (UTC+8)
    Publisher: Shannon: Elsevier Ireland Ltd
    Abstract: Ethnopharmacological relevance
    Ganoderma, known as Lingzhi or Reishi, has been traditionally administered throughout Asia for centuries as a cancer treatment and for other medicinal purposes.
    Aim of the study: To investigate the inhibitory activity and explore the molecular mechanisms of anti-tumor effect on colorectal cancer cells in vitro and in vivo as well as to test the side effects of Ganoderma tsugae.
    Materials and methods: Methanol fraction was obtained from dried fruiting bodies of Ganoderma. TLC and HPLC were performed to differentiate and confirm the identification of different species as well as to quantify the bioactive molecules in methanol extracts of Ganoderma species. MTT and Trypan blue exclusion assay as well as tumorigenesis study were used to assess the anti-tumor effect in vitro and in vivo. Using flow cytometry and Western Blots, we examined further the molecular mechanisms of anti-tumor effect. Finally, biochemical and hematological profiles and pathological examinations were used to evaluate the safety.
    Results: The Ganoderma tsugae extracts inhibit colorectal cancer cell proliferation caused by accumulating cells in G2/M phase, and it may be through downregulation of cyclin A and B1 and upregulation of p21 and p27. Tumorigenesis study in nude mice revealed the extracts caused tumor shrinkage. Additionally, safety assay showed Ganoderma tsugae extracts caused no significant side effects in an animal model.
    Conclusions: This study provides molecular evidence that Ganoderma tsugae extracts exert anti-tumor effects both in vitro and in vivo on colorectal adenocarcinoma cells by inducing G2/M cell cycle arrest. More importantly, no significant physiological changes resulting from treatment with Ganoderma tsugae extracts were observed in the animal model. Therefore, these data provide new insights into the possible therapeutic use of Ganoderma tsugae for treating colorectal cancer.
    Relation: Journal of Ethnopharmacology 120(3), pp.394-401
    DOI: 10.1016/j.jep.2008.09.025
    Appears in Collections:[Graduate Institute & Department of Chemistry] Journal Article

    Files in This Item:

    File Description SizeFormat
    0378-8741_120(3)p394-401.pdf2380KbAdobe PDF296View/Open
    index.html0KbHTML95View/Open

    All items in 機構典藏 are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - Feedback